Olympus (OTCMKTS:OCPNY – Get Free Report) is one of 515 publicly-traded companies in the “Healthcare Equipment & Supplies” industry, but how does it contrast to its peers? We will compare Olympus to similar businesses based on the strength of its valuation, analyst recommendations, institutional ownership, profitability, earnings, risk and dividends.
Analyst Recommendations
This is a summary of recent recommendations and price targets for Olympus and its peers, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Olympus | 0 | 0 | 1 | 0 | 3.00 |
| Olympus Competitors | 4205 | 10291 | 17924 | 794 | 2.46 |
As a group, “Healthcare Equipment & Supplies” companies have a potential upside of 32.34%. Given Olympus’ peers higher probable upside, analysts plainly believe Olympus has less favorable growth aspects than its peers.
Valuation and Earnings
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Olympus | $7.74 billion | $1.03 billion | 21.95 |
| Olympus Competitors | $1.88 billion | $144.09 million | 8.34 |
Olympus has higher revenue and earnings than its peers. Olympus is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.
Insider & Institutional Ownership
0.0% of Olympus shares are owned by institutional investors. Comparatively, 40.1% of shares of all “Healthcare Equipment & Supplies” companies are owned by institutional investors. 14.8% of shares of all “Healthcare Equipment & Supplies” companies are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Risk and Volatility
Olympus has a beta of 0.7, suggesting that its stock price is 30% less volatile than the S&P 500. Comparatively, Olympus’ peers have a beta of 2.53, suggesting that their average stock price is 153% more volatile than the S&P 500.
Dividends
Olympus pays an annual dividend of $0.08 per share and has a dividend yield of 0.4%. Olympus pays out 9.8% of its earnings in the form of a dividend. As a group, “Healthcare Equipment & Supplies” companies pay a dividend yield of 2.4% and pay out 44.6% of their earnings in the form of a dividend.
Profitability
This table compares Olympus and its peers’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Olympus | 13.80% | 24.30% | 9.30% |
| Olympus Competitors | -275.79% | -158.03% | -22.38% |
Summary
Olympus beats its peers on 9 of the 15 factors compared.
Olympus Company Profile
Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment. The Imaging segment deals with digital cameras and recording devices. The Others segment includes biomaterial manufacturing and sales business. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.
Receive News & Ratings for Olympus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus and related companies with MarketBeat.com's FREE daily email newsletter.
